Functional connectome-based predictive modeling of suicidal ideation.

Journal: Journal of affective disorders
Published Date:

Abstract

Suicide represents an egregious threat to society despite major advancements in medicine, in part due to limited knowledge of the biological mechanisms of suicidal behavior. We apply a connectome predictive modeling machine learning approach to identify a reproducible brain network associated with suicidal ideation in the hopes of demonstrating possible targets for novel anti-suicidal therapeutics. Patients were recruited from an inpatient facility at The Menninger Clinic, in Houston, Texas (N = 261; 181 with active and specific suicidal ideation) and had a current major depressive episode and recurrent major depressive disorder, underwent resting-state functional magnetic resonance imaging. The participants' ages ranged from 18 to 70 (mean ± SEM = 31.6 ± 0.8 years) and 136 (52 %) were males. Using this approach, we found a robust and reproducible biomarker of suicidal ideation relative to controls without ideation, showing that increased suicidal ideation was associated with greater internal connectivity and reduced internetwork external connectivity in the central executive, default mode, and dorsal salience networks. We also found evidence for higher external connectivity between ventral salience and sensorimotor/visual networks as being associated with increased suicidal ideation. Overall, these observed differences may reflect reduced network integration and higher segregation of connectivity in individuals with increased suicide risk. Our findings provide avenues for future work to test novel drugs targeting these identified neural alterations, for instance drugs that increase network integration.

Authors

  • Lynnette A Averill
    US Department of Veterans Affairs, USA.
  • Amanda J F Tamman
    Baylor College of Medicine, Menninger Department of Psychiatry and Behavioral Sciences, 1977 Butler Boulevard, Houston, TX 77030, USA; Michael E. DeBakey VA Medical Center, 2002 Holcombe Boulevard, Houston, TX 77030, USA.
  • Samar Fouda
    Duke University School of Medicine, Department of Psychiatry, 905 W Main St, Durham, NC 27701, USA.
  • Christopher L Averill
    US Department of Veterans Affairs, USA.
  • Samaneh Nemati
    University of South Carolina, Department of Communication Sciences and Disorders, 1705 College Street, Columbia, SC, USA.
  • Anya Ragnhildstveit
    Department of Psychiatry, University of Cambridge, Cambridge, UK.
  • Savannah Gosnell
    Baylor College of Medicine, Menninger Department of Psychiatry and Behavioral Sciences, 1977 Butler Boulevard, Houston, TX 77030, USA; Baylor College of Medicine, Department of Neuroscience, Department of Neuroscience One Baylor Plaza, S640, Houston, TX 77030, USA.
  • Teddy J Akiki
    Department of Psychiatry and Behavioral Sciences, Stanford University, 401 Quarry Rd, Palo Alto, CA 94304, USA.
  • Ramiro Salas
    Baylor College of Medicine, Menninger Department of Psychiatry and Behavioral Sciences, 1977 Butler Boulevard, Houston, TX 77030, USA; Michael E. DeBakey VA Medical Center, 2002 Holcombe Boulevard, Houston, TX 77030, USA; Baylor College of Medicine, Department of Neuroscience, Department of Neuroscience One Baylor Plaza, S640, Houston, TX 77030, USA; Michael E. DeBakey VA Medical Center, Center for Translational Research on Inflammatory Diseases, 2002 Holcombe Boulevard, Houston, TX 77030, USA; The Menninger Clinic, 12301 S Main Street, Houston, TX 77035, USA.
  • Chadi G Abdallah
    Department of Psychiatry, Baylor College of Medicine, Houston, TX, USA; Michael E. DeBakey VA Medical Center, Houston, TX, USA; Core for Advanced Magnetic Resonance Imaging (CAMRI), Baylor College of Medicine, Houston, TX, USA. Electronic address: chadi.abdallah@bcm.edu.